Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations

Breast Cancer Research and Treatment

Volumn 112, Issue 1, 2008, Pages 159-164

  Kleibl, Zdenek ^a   Havranek, Ondrej ^b   Novotny, Jan ^b   Kleiblova, Petra ^a   Soucek, Pavel ^c   Pohlreich, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Breast cancer; CHEK2 (Chk2) gene; FHA domain; Mutation analysis

Indexed keywords

CHECKPOINT KINASE 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CHEK2 GENE; CZECH REPUBLIC; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CZECH REPUBLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MUTATION, MISSENSE; PROGNOSIS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES;

EID: 52949100992     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9838-7     Document Type: Article

References (35)

1. H Nevanlinna J Bartek 2006 The CHEK2 gene and inherited breast cancer susceptibility Oncogene 25 5912 5919
2. C Cybulski B Gorski T Huzarski B Masojc M Mierzejewski T Debniak 2004 CHEK2 is a multiorgan cancer susceptibility gene Am J Hum Genet 75 1131 1135
3. J Prokopcova Z Kleibl CM Banwell P Pohlreich 2007 The role of ATM in breast cancer development Breast Cancer Res Treat 104 121 128
4. S Matsuoka M Huang SJ Elledge 1998 Linkage of ATM to cell cycle regulation by the Chk2 protein kinase Science 282 1893 1897
5. J Falck C Lukas M Protopopova J Lukas G Selivanova J Bartek 2001 Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway Oncogene 20 5503 5510
6. J Bartek J Lukas 2003 Chk1 and Chk2 kinases in checkpoint control and cancer Cancer Cell 3 421 429
7. A Traven J Heierhorst 2005 SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins Bioessays 27 397 407
8. A Yoda XZ Xu N Onishi K Toyoshima H Fujimoto N Kato 2006 Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1 J Biol Chem 281 24847 24862
9. D Durocher SP Jackson 2002 The FHA domain FEBS Lett 513 58 66
10. AW Oliver A Paul KJ Boxall SE Barrie GW Aherne MD Garrett 2006 Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange EMBO J 25 3179 3190
11. DW Bell JM Varley TE Szydlo DH Kang DC Wahrer KE Shannon 1999 Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome Science 286 2528 2531
12. N Sodha RS Houlston S Bullock MA Yuille C Chu G Turner 2002 Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome Hum Mutat 20 460 462
13. The CHEK2 Breast Cancer Case-Control Consortium 2004 CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies Am J Hum Genet 74 1175 1182
14. EV Chekmariova AP Sokolenko KG Buslov AG Iyevleva YM Ulibina ME Rozanov 2007 CHEK2 1100delC mutation is frequent among Russian breast cancer patients Breast Cancer Res Treat 100 281 286
15. A Osorio R Rodriguez-Lopez O Diez M de la Hoya MJ Ignacio A Vega 2004 The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population Int J Cancer 108 54 56
16. Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Calo V et al. (2007) BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat: DOI 10.1007/s10549-007-9689-2
17. Gonzalez-Hormazabal P, Castro VG, Blanco R, Gomez F, Peralta O, Waugh E et al. (2007) Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population. Breast Cancer Res Treat: DOI 10.1007/s10549-007-9743-0
18. CG Song Z Hu WT Yuan GH Di ZZ Shen W Huang 2006 CHEK2 c.1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23 443 445
19. T Walsh S Casadei KH Coats E Swisher SM Stray J Higgins 2006 Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JAMA 295 1379 1388
20. X Wu SR Webster J Chen 2001 Characterization of tumor-associated Chk2 mutations J Biol Chem 276 2971 2974
21. MR Dufault B Betz B Wappenschmidt W Hofmann K Bandick A Golla 2004 Limited relevance of the CHEK2 gene in hereditary breast cancer Int J Cancer 110 320 325
22. Z Kleibl J Novotny D Bezdickova R Malik P Kleiblova L Foretova 2005 The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic Breast Cancer Res Treat 90 165 167
23. M Schutte S Seal R Barfoot H Meijers-Heijboer M Wasielewski DG Evans 2003 Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility Am J Hum Genet 72 1023 1028
24. N Sodha S Bullock R Taylor G Mitchell B Guertl-Lackner RD Williams 2002 CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours Br J Cancer 87 1445 1448
25. X Dong L Wang K Taniguchi X Wang JM Cunningham SK McDonnell 2003 Mutations in CHEK2 associated with prostate cancer risk Am J Hum Genet 72 270 280
26. P Vahteristo J Bartkova H Eerola K Syrjakoski S Ojala O Kilpivaara 2002 A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer Am J Hum Genet 71 432 438
27. N Bogdanova N Enssen-Dubrowinskaja S Feshchenko GI Lazjuk YI Rogov O Dammann 2005 Association of two mutations in the CHEK2 gene with breast cancer Int J Cancer 116 263 266
28. O Kilpivaara P Vahteristo J Falck K Syrjakoski H Eerola D Easton 2004 CHEK2 variant I157T may be associated with increased breast cancer risk Int J Cancer 111 543 547
29. C Cybulski B Gorski T Huzarski T Byrski J Gronwald T Debniak 2006 CHEK2-positive breast cancers in young Polish women Clin Cancer Res 12 4832 4835
30. DW Bell SH Kim AK Godwin TA Schiripo PL Harris SM Haserlat 2007 Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts Int J Cancer 121 2661 2667
31. P Brennan J McKay L Moore D Zaridze A Mukeria N Szeszenia-Dabrowska 2007 Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study Hum Mol Genet 16 1794 1801
32. A Sullivan M Yuille C Repellin A Reddy O Reelfs A Bell 2002 Concomitant inactivation of p53 and Chk2 in breast cancer Oncogene 21 1316 1324
33. CW Miller T Ikezoe U Krug WK Hofmann S Tavor V Vegesna 2002 Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors Genes Chromosomes Cancer 33 17 21
34. PJ Smith C Zhang J Wang SL Chew MQ Zhang AR Krainer 2006 An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers Hum Mol Genet 15 2490 2508
35. T Huzarski C Cybulski W Domagala J Gronwald T Byrski M Szwiec 2005 Pathology of breast cancer in women with constitutional CHEK2 mutations Breast Cancer Res Treat 90 187 189